Would you recommend the following article to a politician, an athlete, a business executive, or a scientist?

Is IVAX Ailing? Despite showing strong growth, IVAX (AMEX: IVX) shares are getting pounded after the drug maker posted third-quarter results that still came in below analyst expectations and 
